RapidAI announced the U.S. Food and Drug Administration (FDA) clearance of five new imaging modules: Rapid DeltaFuse, Rapid LMVO, Rapid MLS, Rapid OH, and Rapid Aortic for measurement.

Together, the FDA nods mark a significant expansion of the company’s Rapid Enterprise platform. This reinforces the company’s identity as the only platform that’s purpose-built to bring deep clinical intelligence, workflow integration, and secure IT infrastructure to hospitals.

RapidAI is pursuing AI that surpasses simple triage, letting physicians characterize, quantify, visualize, and track changes over time.

“The FDA clearances of these solutions underscore our commitment to deep clinical AI and reducing cognitive burden for radiologists, as well as supporting superior decision-making and outcomes,” said Karim Karti, CEO of RapidAI. “RapidAI algorithms help set new standards by enabling radiologists to practice at the top of their license, reducing cognitive burden, and improving clinical decision-making for better outcomes in both acute and long-term settings.”

Rapid DeltaFuse automatically aligns and co-registers serial non-contrast head CTs to visualize subtle intracranial changes, solid masses, or ventricular changes. Rapid LVMO enables complete brain coverage on CTA for ischemic stroke—it provides the only complete stroke solution for the entire journey from non-contrast LVO detection all the way to advanced imaging analysis.

Rapid MLS detects and quantifies suspected midline shift, delivering objective visualization with a mean absolute error of 0.8 mm. Rapid OH spots suspected obstructive hydrocephalus be detecting cerebrospinal fluid accumulation in the lateral ventricles and generating alerts in under a minute. Rapid OH qualifies for the CMS NTAP payment, as well.

Rapid Aortic analyzes any CT scan that includes the aorta to help identify and track pathology from the arch to the iliacs. It provides guideline-based measurements with consistent, inter-reader-free results, along with automated 3D reconstruction and visualization for surgical planning. Automated longitudinal comparisons and follow-up notifications simplify surveillance, reduce variability, and save care teams time.

Each module is integrated into the Rapid Edge Cloud, the cloud-first IT platform with on-prem capabilities that ensures continuous service during any disruptions. Further, all modules are integrated into Rapid Navigator Pro, the company’s next-generation radiology solution, as well as the Rapid mobile and web applications.

“Deep clinical AI simplifies what used to be complex,” said Kiran Nandalur, MD, Medical Director, Corewell Health Radiology. “By automatically calculating and visualizing changes we once did manually, RapidAI can reduce the cognitive burden and allow us to concentrate on clinical judgment and interpretation, not data manipulation. This enables us to spend more time on decisions that impact patient care.”